ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
ANI Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
ANI Pharmaceuticals reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, six executives at ANI Pharmaceuticals received on average a compensation package of $2.1M, a 26% decrease compared to previous year.
Average pay of disclosed executives at ANI Pharmaceuticals
Nikhil Lalwani, Chief Executive Officer, received $3.7M in total. 67% of Lalwani's compensation, or $2.5M, was in option awards. Lalwani also received $210K in bonus, $199K in salary, as well as $827K in stock awards.
Stephen P. Carey, Chief Financial Officer, received a compensation package of $2.8M, which increased by 28% compared to previous year. 68% of the compensation package, or $1.9M, was in stock awards.
Robert Schrepfer, Former Senior Vice President, New Business Development and Specialty Sales, earned $2.7M in 2020, a 23% increase compared to previous year.
James G. Marken, Senior Vice President, Operations and Product Development, received $1.9M in 2020, which increases by 34% compared to 2019.
Patrick D. Walsh, Chief Executive Officer, earned $962K in 2020.
Arthur S. Przybyl, Chief Executive Officer, received $858K in 2020, which decreases by 85% compared to 2019.
Related executives
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
You may also like
Source: SEC filing on April 29, 2021.